• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种结合多模态因素预测经动脉化疗栓塞术总生存期的深度学习模型

A Deep Learning Model Combining Multimodal Factors to Predict the Overall Survival of Transarterial Chemoembolization.

作者信息

Sun Zhongqi, Li Xin, Liang Hongwei, Shi Zhongxing, Ren Hongjia

机构信息

Department of Radiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, People's Republic of China.

Department of Interventional Radiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, People's Republic of China.

出版信息

J Hepatocell Carcinoma. 2024 Feb 26;11:385-397. doi: 10.2147/JHC.S443660. eCollection 2024.

DOI:10.2147/JHC.S443660
PMID:38435683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10906280/
Abstract

BACKGROUND

To develop and validate an overall survival (OS) prediction model for transarterial chemoembolization (TACE).

METHODS

In this retrospective study, 301 patients with hepatocellular carcinoma (HCC) who received TACE from 2012 to 2015 were collected. The residual network was used to extract prognostic information from CT images, which was then combined with the clinical factors adjusted by COX regression to predict survival using a modified deep learning model (DLOP). The DLOP model was compared with the residual network model (DLOP), multiple COX regression model (DLOP), Radiomic model (Radiomic), and clinical model.

RESULTS

In the validation cohort, DLOP shows the highest TD AUC of all cohorts, which compared with Radiomic (TD AUC: 0.96vs 0.63) and clinical model (TD AUC: 0.96 vs 0.62) model. DLOP showed significant difference in C index compared with DLOP and DLOP models ( < 0.05). Moreover, the DLOP showed good calibration and overall net benefit. Patients with DLOP model score ≤ 0.902 had better OS (33 months vs 15.5 months, < 0.0001).

CONCLUSION

The deep learning model can effectively predict the patients' overall survival of TACE.

摘要

背景

开发并验证经动脉化疗栓塞术(TACE)的总生存期(OS)预测模型。

方法

在这项回顾性研究中,收集了2012年至2015年接受TACE治疗的301例肝细胞癌(HCC)患者。使用残差网络从CT图像中提取预后信息,然后将其与通过COX回归调整后的临床因素相结合,使用改良的深度学习模型(DLOP)预测生存期。将DLOP模型与残差网络模型(DLOP)、多重COX回归模型(DLOP)、影像组学模型(Radiomic)和临床模型进行比较。

结果

在验证队列中,DLOP在所有队列中显示出最高的TD AUC,与影像组学模型(TD AUC:0.96对0.63)和临床模型(TD AUC:0.96对0.62)相比。与DLOP和DLOP模型相比,DLOP在C指数上显示出显著差异(<0.05)。此外,DLOP显示出良好的校准和总体净效益。DLOP模型评分≤0.902的患者OS更好(33个月对15.5个月,<0.0001)。

结论

深度学习模型可以有效预测TACE患者的总生存期。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb5f/10906280/014569be85d0/JHC-11-385-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb5f/10906280/44e0d3ff47d1/JHC-11-385-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb5f/10906280/81fff9c3899e/JHC-11-385-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb5f/10906280/7e7631404af0/JHC-11-385-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb5f/10906280/066814c9db0a/JHC-11-385-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb5f/10906280/48b3275eb999/JHC-11-385-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb5f/10906280/014569be85d0/JHC-11-385-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb5f/10906280/44e0d3ff47d1/JHC-11-385-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb5f/10906280/81fff9c3899e/JHC-11-385-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb5f/10906280/7e7631404af0/JHC-11-385-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb5f/10906280/066814c9db0a/JHC-11-385-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb5f/10906280/48b3275eb999/JHC-11-385-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb5f/10906280/014569be85d0/JHC-11-385-g0006.jpg

相似文献

1
A Deep Learning Model Combining Multimodal Factors to Predict the Overall Survival of Transarterial Chemoembolization.一种结合多模态因素预测经动脉化疗栓塞术总生存期的深度学习模型
J Hepatocell Carcinoma. 2024 Feb 26;11:385-397. doi: 10.2147/JHC.S443660. eCollection 2024.
2
Contrast-Enhanced CT Imaging Features Combined with Clinical Factors to Predict the Efficacy and Prognosis for Transarterial Chemoembolization of Hepatocellular Carcinoma.联合增强 CT 影像学特征与临床因素预测肝细胞癌经导管肝动脉化疗栓塞术的疗效和预后。
Acad Radiol. 2023 Sep;30 Suppl 1:S81-S91. doi: 10.1016/j.acra.2022.12.031. Epub 2023 Feb 17.
3
Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus Sorafenib.深度学习预测经动脉化疗栓塞联合索拉非尼治疗的不可切除肝细胞癌患者的总生存期。
Front Oncol. 2020 Sep 30;10:593292. doi: 10.3389/fonc.2020.593292. eCollection 2020.
4
Transhepatectomy combined with arterial chemoembolization and transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a clinical prognostic analysis.肝切除术联合动脉化疗栓塞和经导管动脉化疗栓塞治疗肝细胞癌:临床预后分析。
BMC Gastroenterol. 2023 Sep 5;23(1):299. doi: 10.1186/s12876-023-02886-1.
5
CT-based radiomics nomogram for prediction of survival after transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma and portal vein tumor thrombus.基于 CT 的放射组学列线图预测肝癌伴门静脉癌栓患者经载药微球动脉化疗栓塞术后的生存情况。
Eur Radiol. 2023 Dec;33(12):8715-8726. doi: 10.1007/s00330-023-09830-7. Epub 2023 Jul 12.
6
Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.基于计算机断层扫描的影像组学列线图用于预测肝细胞癌经动脉化疗栓塞难治性的研究进展
World J Gastroenterol. 2021 Jan 14;27(2):189-207. doi: 10.3748/wjg.v27.i2.189.
7
Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.经动脉化疗栓塞联合重组人5型腺病毒H101可延长中晚期肝细胞癌患者的总生存期:一项预后列线图研究
Chin J Cancer. 2017 Jul 20;36(1):59. doi: 10.1186/s40880-017-0227-2.
8
Development and Validation of Deep Learning Model for Intermediate-Stage Hepatocellular Carcinoma Survival with Transarterial Chemoembolization (MC-hccAI 002): a Retrospective, Multicenter, Cohort Study.经动脉化疗栓塞术治疗中期肝细胞癌生存情况的深度学习模型(MC-hccAI 002)的开发与验证:一项回顾性、多中心队列研究
J Cancer. 2024 Feb 17;15(7):2066-2073. doi: 10.7150/jca.91501. eCollection 2024.
9
Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging.基于 CT 影像预测肝细胞癌经动脉化疗栓塞治疗反应的残差卷积神经网络。
Eur Radiol. 2020 Jan;30(1):413-424. doi: 10.1007/s00330-019-06318-1. Epub 2019 Jul 22.
10
Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound.利用超声造影人工智能技术准确预测肝癌患者经动脉化疗栓塞治疗的反应。
Eur Radiol. 2020 Apr;30(4):2365-2376. doi: 10.1007/s00330-019-06553-6. Epub 2020 Jan 3.

引用本文的文献

1
Applications of artificial intelligence in interventional oncology: An up-to-date review of the literature.人工智能在介入肿瘤学中的应用:文献综述
Jpn J Radiol. 2025 Feb;43(2):164-176. doi: 10.1007/s11604-024-01668-3. Epub 2024 Oct 2.

本文引用的文献

1
Prognostic Performance of the China Liver Cancer Staging System in Hepatocellular Carcinoma Following Transarterial Chemoembolization.中国肝癌分期系统在经动脉化疗栓塞术后肝细胞癌中的预后评估性能
J Clin Transl Hepatol. 2023 Nov 28;11(6):1321-1328. doi: 10.14218/JCTH.2023.00099. Epub 2023 Jul 7.
2
Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization.术后辅助经动脉化疗栓塞治疗肝细胞癌患者的预后因素和创新的列线图模型。
Ann Med. 2023 Dec;55(1):2199219. doi: 10.1080/07853890.2023.2199219.
3
Preoperative Nomogram Incorporating Clinical Factors, Serological Markers and LI-RADS MRI Features to Predict Early Recurrence of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
术前列线图纳入临床因素、血清标志物和 LI-RADS MRI 特征预测经肝动脉化疗栓塞治疗的肝细胞癌早期复发。
Acad Radiol. 2023 Jul;30(7):1288-1297. doi: 10.1016/j.acra.2022.10.020. Epub 2022 Nov 21.
4
Development and validation of a deep learning model for survival prognosis of transcatheter arterial chemoembolization in patients with intermediate-stage hepatocellular carcinoma.用于中期肝细胞癌患者经动脉化疗栓塞术生存预后的深度学习模型的开发与验证
Eur J Radiol. 2022 Nov;156:110527. doi: 10.1016/j.ejrad.2022.110527. Epub 2022 Sep 19.
5
Hepatocellular carcinoma.肝细胞癌
Lancet. 2022 Oct 15;400(10360):1345-1362. doi: 10.1016/S0140-6736(22)01200-4. Epub 2022 Sep 6.
6
Radiologic Response as a Prognostic Factor in Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion after Transarterial Chemoembolization and Radiotherapy.放射学反应作为经动脉化疗栓塞和放疗后伴有宏观血管侵犯的晚期肝细胞癌的预后因素
Liver Cancer. 2021 Dec 7;11(2):152-161. doi: 10.1159/000521227. eCollection 2022 Apr.
7
Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study.利用多任务深度学习从胃癌CT图像预测腹膜复发和无病生存期:一项回顾性研究
Lancet Digit Health. 2022 May;4(5):e340-e350. doi: 10.1016/S2589-7500(22)00040-1.
8
Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes.与临床结局和基因组表型相关的肝细胞癌共识亚型。
Hepatology. 2022 Dec;76(6):1634-1648. doi: 10.1002/hep.32490. Epub 2022 Jun 29.
9
Survival Analysis Using Albumin-Bilirubin (ALBI) Grade for Patients Treated with Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular Carcinoma.使用白蛋白-胆红素(ALBI)分级对接受药物洗脱栓塞经动脉化疗栓塞治疗的肝细胞癌患者进行生存分析
J Vasc Interv Radiol. 2022 May;33(5):510-517.e1. doi: 10.1016/j.jvir.2022.02.005. Epub 2022 Feb 9.
10
Multi-task deep learning network to predict future macrovascular invasion in hepatocellular carcinoma.用于预测肝细胞癌未来大血管侵犯的多任务深度学习网络。
EClinicalMedicine. 2021 Dec 9;42:101201. doi: 10.1016/j.eclinm.2021.101201. eCollection 2021 Dec.